Cargando…

Interstitial lung abnormalities: Real‐world evidence

Detalles Bibliográficos
Autores principales:	Rôlo Silvestre, Carina, Custódio, Catarina, Clemente, Susana, Rodrigues, Silvia, Furtado, Sofia Tello, Maio, Rui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120401/ https://www.ncbi.nlm.nih.gov/pubmed/37091361 http://dx.doi.org/10.1002/hsr2.1216

Ejemplares similares

Pinocchio, Interstitial Lung Abnormalities, and Becoming a Real Disease
por: Putman, Rachel K., et al.
Publicado: (2023)

Interstitial lung abnormality (ILA) and nonspecific interstitial pneumonia (NSIP)
por: Hino, Takuya, et al.
Publicado: (2021)

Interstitial lung abnormalities and physical function
por: Axelsson, Gisli Thor, et al.
Publicado: (2018)

Interstitial Lung Abnormalities: An Evolving Entity
por: Tomassetti, Sara, et al.
Publicado: (2022)

Barriers to timely diagnosis of interstitial lung disease in the real world: the INTENSITY survey
por: Cosgrove, Gregory P., et al.
Publicado: (2018)

Risk Stratifying Interstitial Lung Abnormalities to Guide Early Diagnosis of Interstitial Lung Diseases
por: Wijsenbeek, Marlies S., et al.
Publicado: (2022)

Interstitial lung abnormalities: do symptoms matter?
por: Patel, Avignat S.
Publicado: (2023)

Mycophenolate mofetil for scleroderma-related interstitial lung disease: A real world experience
por: Baqir, Misbah, et al.
Publicado: (2017)

Real-world impact of antifibrotics on prognosis in patients with progressive fibrosing interstitial lung disease
por: Niitsu, Takayuki, et al.
Publicado: (2023)

Nintedanib administration after the onset of acute exacerbation of interstitial lung disease in the real world
por: Kato, Motoyasu, et al.
Publicado: (2023)

Elexacaftor/tezacaftor/ivacaftor-real-world clinical effectiveness and safety. A single-center Portuguese study
por: Lopes, Kelly, et al.
Publicado: (2023)

The world of rare interstitial lung diseases
por: Buschulte, Katharina, et al.
Publicado: (2023)

Almonertinib-induced interstitial lung disease in a lung adenocarcinoma patient complicated with interstitial lung abnormality
por: Zhou, Qian, et al.
Publicado: (2023)

Interstitial lung disease and pre-capillary pulmonary hypertension in neurofibromatosis type 1
por: Rodrigues, Daniela, et al.
Publicado: (2018)

Abnormalities of the Amygdala in schizophrenia: a real world study
por: Zheng, Guangen, et al.
Publicado: (2023)

The application of transbronchial cryobiopsy in interstitial lung disease: a prospective, multicenter, real-world study
por: Chen, Xiaobo, et al.
Publicado: (2021)

Potential Metabolic Biomarkers to Identify Interstitial Lung Abnormalities
por: Tan, Yong, et al.
Publicado: (2016)

Subclinical Interstitial Lung Abnormalities: Lumping and Splitting Revisited
por: Walsh, Simon L. F., et al.
Publicado: (2019)

Increased respiratory morbidity in individuals with interstitial lung abnormalities
por: Hoyer, Nils, et al.
Publicado: (2020)

Interstitial Lung Abnormalities: What Radiologists Should Know
por: Chae, Kum Ju, et al.
Publicado: (2021)

Interstitial lung abnormalities – current knowledge and future directions
por: Axelsson, Gisli Thor, et al.
Publicado: (2021)

Interstitial Lung Abnormalities and Aging Biomarkers: A Mediation
por: Oldham, Justin M.
Publicado: (2021)

Post COVID Interstitial Lung Abnormalities—Incidence and Management
por: Robertshaw, Mark, et al.
Publicado: (2023)

Bronchial epithelial gene expression and interstitial lung abnormalities
por: Menon, Aravind A., et al.
Publicado: (2023)

Real-World Evidence for Equality
por: Johnson, C. Erwin, et al.
Publicado: (2021)

Editorial: Real-world data and real-world evidence in hematologic malignancies
por: Malagola, Michele, et al.
Publicado: (2023)

Obtaining real-world evidence: the Salford Lung Study
por: New, John P, et al.
Publicado: (2014)

Clinical Characteristics and Disease Course of Fibrosing Interstitial Lung Disease Patients in a Real-World Setting
por: Kilpeläinen, Maritta, et al.
Publicado: (2023)

Editorial: Interstitial Lung Disease Around the World
por: Wijsenbeek, Marlies, et al.
Publicado: (2022)

Real world evidence: Patients with refractory pemphigus treated with Rituximab
por: Perifani, Vagiani, et al.
Publicado: (2021)

Interstitial lung abnormalities a risk factor for rheumatoid arthritis interstitial lung disease progression: what's new
por: Leone, Paolo Maria, et al.
Publicado: (2020)

Preserved Ratio Impaired Spirometry and Interstitial Lung Abnormalities in Smokers
por: Marruchella, Almerico
Publicado: (2019)

Erratum: The Association of Aging Biomarkers, Interstitial Lung Abnormalities, and Mortality
Publicado: (2022)

Adult Interstitial Lung Abnormalities: The New Frontier of Pulmonary Fibrosis
por: Luo, FengMing, et al.
Publicado: (2023)

Informing real-world practice with real-world evidence: the value of PRECIS-2
por: Neta, Gila, et al.
Publicado: (2018)

Proceed with Caution When Using Real World Data and Real World Evidence
por: Kim, Hun-Sung, et al.
Publicado: (2019)

4505 Implementation of Real-World Data and Real-World Evidence in Clinical Studies
por: Pham, Jessica, et al.
Publicado: (2020)

The Missing Reality of Real Life in Real‐World Evidence
por: Okun, Sally
Publicado: (2019)

Interstitial lung abnormalities and interstitial lung diseases associated with cigarette smoking in a rural cohort undergoing surgical resection
por: Sangani, Rahul G., et al.
Publicado: (2022)

Real world evidence: An Indian perspective
por: Dang, Amit, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_pif532a7s9nr5181vgsu146n9v